Endometrial cancer drug gets breakthrough therapy designatio

HUTCHMED has announced that the NMPA has granted Breakthrough Therapy Designation for its advanced endometrial cancer treatment.

Related Keywords

Japan , China , Eli Lilly , Innovent Biologics Inc , European Medicines Agency , Hutchmed China , Drug Administration , Japan Pharmaceuticals , National Reimbursement Drug List , Takeda Pharmaceutical Company , Devices Agency , Drug Evaluation , National Medical Products Administration , Breakthrough Therapy Designation , Prescription Drug User Fee Act , Medical Devices Agency , Takeda Pharmaceutical Company Limited , Innovent Biologics ,